Literature DB >> 19889143

Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals.

C M Martin1, J A Welge, N J Shire, S D Rouster, M T Shata, K E Sherman, J T Blackard.   

Abstract

Occult hepatitis B virus (O-HBV) infection is characterized by the presence of HBV DNA without detectable hepatitis B surface antigen (HBV DNA+/HBsAg-) in the serum. Although O-HBV is more prevalent during HBV/HIV co-infection, analysis of HBV mutations in co-infected patients is limited. In this preliminary study, HBV PreSurface (PreS) and surface (S) regions were amplified from 33 HIV-positive patient serum samples - 27 chronic HBV (C-HBV) and six O-HBV infections. HBV genotype was determined by phylogenetic analysis, while quasispecies diversity was quantified for the PreS, S and overlapping polymerase regions. C-HBV infections harboured genotypes A, D and G, compared to A, E, G and one mixed A/G infection for O-HBV. Interestingly, nonsynonymous-synonymous mutation values indicated positive immune selection in three regions for O-HBV vs one for C-HBV. Sequence analysis further identified new O-HBV mutations, in addition to several previously reported mutations within the HBsAg antigenic determinant. Several of these O-HBV mutations likely contribute to the lack of detectable HBsAg in O-HBV infection by interfering with detection in serologic assays, altering antigen secretion and/or decreasing replicative fitness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889143      PMCID: PMC3032083          DOI: 10.1111/j.1365-2893.2009.01214.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  48 in total

Review 1.  Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region.

Authors:  L J Stuyver; S A Locarnini; A Lok; D D Richman; W F Carman; J L Dienstag; R F Schinazi
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

2.  Distribution of hepatitis B virus genotypes among American blood donors determined with a PreS2 epitope enzyme-linked immunosorbent assay kit.

Authors:  Takashi Moriya; Isamu K Kuramoto; Hiroshi Yoshizawa; Paul V Holland
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Isolation, characterization and biological significance of hepatitis B virus mutants from serum of a patient with immunologically negative HBV infection.

Authors:  M Schories; T Peters; J Rasenack
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

4.  MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment.

Authors:  Sudhir Kumar; Koichiro Tamura; Masatoshi Nei
Journal:  Brief Bioinform       Date:  2004-06       Impact factor: 11.622

Review 5.  Hepatitis B virus genotypes: do they play a role in the outcome of HBV infection?

Authors:  Scott K Fung; Anna S F Lok
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

6.  Transmission of hepatitis B from hepatitis-B-seronegative subjects.

Authors:  V Thiers; E Nakajima; D Kremsdorf; D Mack; H Schellekens; F Driss; A Goudeau; J Wands; J Sninsky; P Tiollais
Journal:  Lancet       Date:  1988-12-03       Impact factor: 79.321

7.  A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness.

Authors:  L Stuyver; S De Gendt; C Van Geyt; F Zoulim; M Fried; R F Schinazi; R Rossau
Journal:  J Gen Virol       Date:  2000-01       Impact factor: 3.891

8.  A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency.

Authors:  X Lin; Z H Yuan; L Wu; J P Ding; Y M Wen
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

9.  High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum.

Authors:  K M Weinberger; T Bauer; S Böhm; W Jilg
Journal:  J Gen Virol       Date:  2000-05       Impact factor: 3.891

10.  Selection of hepatitis B virus polymerase mutants with enhanced replication by lamivudine treatment after liver transplantation.

Authors:  C-Thomas Bock; Hans L Tillmann; Joseph Torresi; Jürgen Klempnauer; Stephen Locarnini; Michael P Manns; Christian Trautwein
Journal:  Gastroenterology       Date:  2002-02       Impact factor: 22.682

View more
  16 in total

1.  Hepatitis B virus (HBV) X gene diversity and evidence of recombination in HBV/HIV co-infected persons.

Authors:  Christina M Martin; Jeffrey A Welge; Jason T Blackard
Journal:  J Med Virol       Date:  2011-04-22       Impact factor: 2.327

2.  Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro.

Authors:  C M Martin; J A Welge; S D Rouster; M T Shata; K E Sherman; J T Blackard
Journal:  J Viral Hepat       Date:  2012-06-04       Impact factor: 3.728

3.  Mutations associated with occult hepatitis B in HIV-positive South Africans.

Authors:  Eleanor A Powell; Maemu P Gededzha; Michael Rentz; Nare J Rakgole; Selokela G Selabe; Tebogo A Seleise; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Med Virol       Date:  2014-08-27       Impact factor: 2.327

4.  Functional analysis of 'a' determinant mutations associated with occult HBV in HIV-positive South Africans.

Authors:  Eleanor A Powell; Ceejay L Boyce; Maemu P Gededzha; Selokela G Selabe; M Jeffrey Mphahlele; Jason T Blackard
Journal:  J Gen Virol       Date:  2016-03-31       Impact factor: 3.891

5.  Occult hepatitis B virus infection among Mexican human immunodeficiency virus-1-infected patients.

Authors:  Ma Teresa Alvarez-Muñoz; Angelica Maldonado-Rodriguez; Othon Rojas-Montes; Rocio Torres-Ibarra; Fernanda Gutierrez-Escolano; Guillermo Vazquez-Rosales; Alejandro Gomez; Onofre Muñoz; Javier Torres; Rosalia Lira
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

6.  HBV whole-genome mutation profile in HIV-1/HBV coinfected patients in a long-term follow-up study.

Authors:  S Taffon; D Genovese; M Blasi; P Pierotti; A Degli Esposti; S Catone; P Chionne; B Pulimanti; A Candido; S Dettori; M E Tosti; C Argentini; F Mazzotta; M Rapicetta
Journal:  Infection       Date:  2014-04-04       Impact factor: 3.553

7.  Unusual presentation of hepatitis B serological markers in an Amerindian community of Venezuela with a majority of occult cases.

Authors:  Nathalia E Cardona; Carmen L Loureiro; Domingo J Garzaro; María C Duarte; Daisy M García; Milian C Pacheco; Isabelle Chemin; Flor H Pujol
Journal:  Virol J       Date:  2011-12-09       Impact factor: 4.099

8.  Hepatitis B virus genotype G infection in a Turkish patient undergoing hemodialysis therapy.

Authors:  Murat Sayan; Cengiz Dogan
Journal:  Hepat Mon       Date:  2012-02-29       Impact factor: 0.660

Review 9.  Potential mutations associated with occult hepatitis B virus status.

Authors:  Sima Besharat; Aezam Katoonizadeh; Abdolvahab Moradi
Journal:  Hepat Mon       Date:  2014-05-03       Impact factor: 0.660

10.  Occult Hepatitis B Virus Infection in a Previously Vaccinated Injection Drug User.

Authors:  Eleanor A Powell; Sanam Razeghi; Stephen Zucker; Jason T Blackard
Journal:  Hepat Mon       Date:  2016-02-20       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.